Royalty Pharma EVP Marshall Urist Reports Sale of Common Shares
Marshall Urist, EVP of Research & Investments at Royalty Pharma, reported the sale of common shares. The information was published by Royalty Pharma via the U.S. SEC's EDGAR system on December 3, 2025. This brief was generated by Public Technologies using AI and is for informational purposes only.
Marshall Urist, EVP, Research & Investments, reported a disposal of common shares of Royalty Pharma plc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001838139-25-000006), on December 03, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
